Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Regenxbio (RGNX) Gross Profit (2016 - 2024)

Historic Gross Profit for Regenxbio (RGNX) over the last 11 years, with Q4 2024 value amounting to $14.9 million.

  • Regenxbio's Gross Profit rose 3572.67% to $14.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $49.8 million, marking a year-over-year decrease of 616.27%. This contributed to the annual value of $49.8 million for FY2024, which is 616.27% down from last year.
  • Per Regenxbio's latest filing, its Gross Profit stood at $14.9 million for Q4 2024, which was up 3572.67% from $11.8 million recorded in Q3 2024.
  • In the past 5 years, Regenxbio's Gross Profit registered a high of $375.6 million during Q4 2021, and its lowest value of $6.5 million during Q1 2022.
  • Its 5-year average for Gross Profit is $34.9 million, with a median of $13.7 million in 2021.
  • As far as peak fluctuations go, Regenxbio's Gross Profit soared by 325714.16% in 2021, and later plummeted by 9505.8% in 2022.
  • Over the past 5 years, Regenxbio's Gross Profit (Quarter) stood at $11.2 million in 2020, then skyrocketed by 3257.14% to $375.6 million in 2021, then crashed by 95.06% to $18.6 million in 2022, then crashed by 40.87% to $11.0 million in 2023, then skyrocketed by 35.73% to $14.9 million in 2024.
  • Its Gross Profit stands at $14.9 million for Q4 2024, versus $11.8 million for Q3 2024 and $11.7 million for Q2 2024.